Lead Sponsor

Medtronic - MITG

Age

0 - No limit years

Sex

ALL

Healthy Volunteers

Yes

•Parent or legal guardian is willing and able to provide informed consent prior to any study procedures being performed.
•Subject is expected to be able to participate for the duration of the evaluation in the delivery room. In most instances, the length of the study will not exceed the anticipated duration of ECG monitoring.
•Subject is ≥ 29 weeks gestational age.
•Subject can accommodate multiple sensors.

•Subjects that have an existing health condition, in which the investigator determines that safe or accurate oximetry measures may not be obtained at the areas where the PO sensor could be placed. For example, major congenital anomalies, limb anomalies or anyone with abrasions or surface lesions on the contact areas would be excluded.
•Any subject whose treatment or condition would be compromised if they were to participate in this study and any patient whose use of a pulse oximeter and sensor would present a potential for serious risk to health, safety, or welfare.
•Currently participating in any other study expected to confound study results in the opinion of the investigator.

Related studies

NCT07251790 · Respiratory Distress Syndrome, Newborn, Respiratory Distress Syndrome in Premature Infant

NCT07344714 · Respiratory Distress Syndrome, Newborn, Respiratory Distress Syndrome in Premature Infant, and more

NCT02601339 · Hemorrhage, Premature Infants, and more

NCT07261254 · Income, Infant, Newborn, and more

NCT06417385 · Premature Birth, Breastfeeding, Exclusive, and more

Pulse Oximetry Performance Comparison in Newborns